Pharmaceutical Solutions Industry Ltd "PSI

Pharmaceutical Solutions Industry Ltd "PSI" is a prominent manufacturer specializing in sterile and injectable pharmaceutical products. Established in 1979, the company has built a robust reputation within the Middle East and Africa, focusing on high-quality therapeutic solutions. Their core portfolio includes intravenous solutions, pain management therapies, and haemodialysis products, all manufactured within GMP-certified facilities. With over 45 years of industry experience, the firm maintains a strong commitment to clinical excellence and patient safety across its diverse therapeutic groups.

The company operates with a workforce of 500-1,000 employees, supporting a single, highly specialized manufacturing location. Pharmaceutical Solutions Industry Ltd "PSI" distinguishes itself through continuous innovation, most notably by developing the world's first Ibuprofen intravenous infusion. This technical achievement underscores their dedication to advancing medical care and providing hospitals with essential, life-saving treatments. By integrating advanced manufacturing processes with rigorous quality control, the organization ensures that its pharmaceutical output meets international standards for safety and efficacy in clinical environments.

Strategically positioned to serve the healthcare sector, the company emphasizes accessibility and corporate social responsibility in its operations. With annual revenue reaching $119.4M, their business model focuses on B2B distribution, ensuring that critical medical supplies reach hospitals and patients efficiently. As the organization continues to expand its influence in the pharmaceutical sector, it remains dedicated to its founding mission of delivering reliable, high-quality healthcare solutions. Meet Pharmaceutical Solutions Industry Ltd "PSI"'s team to learn more about the leadership driving these advancements in the pharmaceutical industry.